Royal Society of Chemistry

Announcing the winners of this year’s #RSCEmergingTech Competition! Congratulations to Imperial College London and Dr Othman Al Musaimi, PhD, Lecturer in Medicinal Chemistry, Orthogonal Peptides, who won in our Enabling Technologies category with re-inventing Solid-Phase Peptide Synthesis. #RSCIndustry Learn more about Orthogonal Peptides here: https://lnkd.in/gvs9x88i

As #DisabilityPride Month draws to a close, remember that if you experience barriers or limitations related to a mental or physical disability, long-term health condition or impairment, you can check out our resources and get support: https://rsc.li/3Y2sca6

Congratulations to Anaphite who have had their training accredited by the RSC. This accreditation from the Royal Society of Chemistry provides employees with a structured pathway to achieving our professional development awards. Recognising and retaining talent, providing a mark of excellence for your future workforce.

Habit getting out of control? If you or someone you care about is struggling with a habit, an addiction or a dependency, call or use our addiction support service in confidence. 0800 084 3451 (UK Freephone) 44 1223 853549 (International) We’re here for you: https://rsc.li/3yeVw2B #RSCCommFund

Don't let the #ChemistryWeek grant deadline sneak up on you! Prepare your submissions and make sure to apply by August 5th! Check out the full details here 👉 https://rsc.li/4cr8d9o

Our 2nd Edition of the book "Drug Discovery for Schizophrenia" is on its way to release published soon by The Royal Society of Chemistry. The new collection of research will enhance our understanding of pathological neural communication between the peripheral nervous system (PNS) and central nervous system (CNS) in patients with schizophrenia. I'm very thankful to all contributors to our updated Edition, including Prof. John Waddington (RCSI, Dublin, Ireland) and Dr. Xuechu Zhen (Soochow University, China), Dr. Jean-Philippe Krieger and Dr. Urs Meyer (Zurich University, Switzerland), Dr. Hai-Qian Zhoua, Dr. Qian Lib and Dr. Dong-Min Yina (Shanghai Jiao Tong University, China), Dr. Dennis Kätzel (Ulm University, Germany), Dr. Steven Clapcote (Leeds University, UK), Dr. Clement Zai with co-authors (University of Toronto, Canada; Stanley Center for Psychiatric Research at Broad Institute of MIT, Harvard, USA), Sylvia Okafor (University of Toronto, Canada), Dr. Bernard Le Foll with co-authors (University of Toronto, University Health Network, Canada), Dr. Ekaterina Merkulova (Institute of Neurosciences and Medicine, Novosibirsk, Russia). I do appreciate effective communication with Liangqi Li and Katie Morrey from the RCS to make it real. Briefly, the second edition of the book presents current evidence that views schizophrenia as a mild abnormal maldevelopment of the entire body. This includes impaired functioning of sensory systems (e.g. olfaction), changes in blood biochemistry, and autonomic nervous system (e.g. vagal body-to-brain communication). Alternative approaches to prevent and treat schizophrenia involve advanced techniques such as non-invasive brain stimulation, local administration of compounds (e.g. intranasally) targeting PNS-based cellular-molecular pathways, or development of opto- and chemo-genetics. Two chapters focus on the genetics of schizophrenia, leveraging technological advancements in high-throughput genomics and computational biology. These tools help identify novel therapeutic targets and enable the safe repurposing of existing medications. Systematically accumulating knowledge about PNS-CNS pathological mechanisms will benefit psychiatric neuroscience, offering fresh perspectives for drug discovery. Overall, the book synthesizes expert opinions from academia and clinical studies, covering progress in genetics, pharmacogenetics, molecular-cellular neuroscience, neurobiology, pharmacology and animal models.  To whom is interested, just in case here is the link to the 1st Edition released in 2015: https://lnkd.in/gWM-uJjn

Present your work on biomineralisation and network with leading experts in the field. Our Faraday Discussion on Advanced imaging techniques in biomineralisation will focus on the latest advances in biomineralisation research. Showcase your work, connect with your community and be published in the journal volume. Be part of the conversation – submit your oral abstract by 9 September: rsc.li/biomineral-fd2025

Join #FICCI - #Publicon 2024, as Ajit Kumar S. discusses the 'Role of technology in making OA publishing shift' on July 25, 2024, Meet us at FICCI, New Delhi. #OpenAccess #Publishing. Secure your spot today: https://lnkd.in/gy96fn_J

Impact factor, CiteScore and more – Energy Advances now has metrics. We want to thank our whole community – our authors, readers, reviewers, and board members – for making the first two years of Energy Advances so memorable. We can’t wait to see what the future holds. Discover our metrics: https://rsc.li/3j6lCdM

Announcing the Horizons symposium 2024. Join us to explore our theme, polymers at the human interface and the latest developments in #MaterialsScience, from Materials Horizons and Nanoscale Horizons The two-day conference will take place in Beijing in November 2024. Don’t miss the opportunity to join us to hear the latest cutting-edge research, share your own work and network with your community. Find out more: rsc.li/horizonssymp2024